We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$829M
Cap. Flow %
4.68%
Top 10 Hldgs %
32.88%
Holding
1,375
New
60
Increased
737
Reduced
285
Closed
62

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$115M
2
ESS icon
Essex Property Trust
ESS
+$110M
3
AAPL icon
Apple
AAPL
+$103M
4
TSLA icon
Tesla
TSLA
+$101M
5
MSFT icon
Microsoft
MSFT
+$97.5M

Top Sells

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$122M
2
SUI icon
Sun Communities
SUI
+$107M
3
SPG icon
Simon Property Group
SPG
+$104M
4
WPC icon
W.P. Carey
WPC
+$76.5M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$70.5M

Sector Composition

Rank Sector Weight
1 Real Estate 45.88%
2 Technology 16.72%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVIR icon
1276
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
– –
CHRS icon
1277
Coherus Oncology
CHRS
$222M
$1K ﹤0.01%
262
– –
CRBU icon
1278
Caribou Biosciences
CRBU
$148M
$1K ﹤0.01%
176
– –
ERAS icon
1279
Erasca
ERAS
$6.3B
$1K ﹤0.01%
354
– –
FULC icon
1280
Fulcrum Therapeutics
FULC
$248M
$1K ﹤0.01%
138
– –
HROW icon
1281
Harrow
HROW
$1.47B
$1K ﹤0.01%
110
– –
HUMA icon
1282
Humacyte
HUMA
$170M
$1K ﹤0.01%
301
– –
LXRX icon
1283
Lexicon Pharmaceuticals
LXRX
$1.04B
$1K ﹤0.01%
434
– –
MGTX icon
1284
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
130
– –
MXCT icon
1285
MaxCyte
MXCT
$112M
$1K ﹤0.01%
293
– –
NAUT icon
1286
Nautilus Biotechnolgy
NAUT
$152M
$1K ﹤0.01%
362
– –
NVAX icon
1287
Novavax
NVAX
$1.21B
$1K ﹤0.01%
291
– –
PGEN icon
1288
Precigen
PGEN
$1.97B
$1K ﹤0.01%
708
– –
QURE icon
1289
uniQure
QURE
$2.52B
$1K ﹤0.01%
158
– –
RAPT
1290
DELISTED
RAPT Therapeutics
RAPT
$1K ﹤0.01%
13
– –
TERN
1291
DELISTED
Terns Pharmaceuticals
TERN
$1K ﹤0.01%
151
– –
THRD
1292
DELISTED
Third Harmonic Bio
THRD
$1K ﹤0.01%
+149
New +$1.45K
URGN icon
1293
UroGen Pharma
URGN
$1.99B
$1K ﹤0.01%
48
– –
VNDA icon
1294
Vanda Pharmaceuticals
VNDA
$310M
$1K ﹤0.01%
191
– –
VTYX
1295
DELISTED
Ventyx Biosciences
VTYX
$1K ﹤0.01%
228
– –
XERS icon
1296
Xeris Biopharma Holdings
XERS
$1.42B
$1K ﹤0.01%
404
– –
ME
1297
DELISTED
23andMe Holding Co
ME
$1K ﹤0.01%
48
– –
ACLS icon
1298
Axcelis
ACLS
$3.69B
– –
-100
Closed -$13K
ACRS icon
1299
Aclaris Therapeutics
ACRS
$744M
$0 ﹤0.01%
248
– –
AEO icon
1300
American Eagle Outfitters
AEO
$3.04B
– –
-1,000
Closed -$21K
50 51
52
53 54

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2024 Portfolio in Review

As of Q1 2024, Daiwa Securities Group held 1,375 positions worth $17.7B, up 10% from $16.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group deployed $829M of net new capital in Q1 2024, opening 60 new positions and adding to 737 existing holdings. Its largest new stake was American Healthcare REIT: 241,461 shares worth $3.56M.

By sector, the portfolio is most concentrated in Real Estate at 46% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $122M trimmed.

  • Daiwa Securities Group's largest Q1 2024 buy was American Healthcare REIT: 241,461 shares worth $3.56M.
  • Daiwa Securities Group added most to Equinix in Q1 2024, an estimated $115M increase.
  • Daiwa Securities Group's biggest Q1 2024 reduction was Mid-America Apartment Communities, cutting an estimated $122M.
  • Daiwa Securities Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $70.5M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $17.7B portfolio in Q1 2024.
  • Daiwa Securities Group opened 60 new positions and closed 62 in Q1 2024.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $17.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.